| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 7 Nov 2025 | 4 Nov 2025 |
| Integrated Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2025 inter alia to consider and approve Pursuant to regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 we hereby inform you that the Meeting of the Board of Directors of the Company will be held on Friday 07th November 2025 inter alia where along with other matters the Board shall consider and approve the Standalone Unaudited Financial Results of the Company for the quarter and half year ended 30th September 2025. Approval of Unaudited results for the quarter and half year ender 30th September, 2025 for the FY 2025-26 Pursuant to the provisions of Regulation 30 (read with Part A of Schedule III) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), and in continuation to our letter dated 04th November 2025, we hereby report the outcome of the meeting of the Board of Directors held today, i.e. Friday, 07th November, 2025, inter-alia, to consider and approve the following: 1. Considered and approved the unaudited financial results for the quarter ended 30th September, 2025 together with the Limited Review Report by the Auditors. (As Per BSE Announcement Dated on:07.11.2025) | ||
| Board Meeting | 28 Aug 2025 | 28 Aug 2025 |
| Outcome of Board Meeting and Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for appointment of an independent director having DIN - 11255979 and cessation of an independent director having DIN - 01478375 and other matters Outcome of the Board meeting and Disclosure under Regulation 30 of SEBI(LODR), Regulation 2015 for appointment of Independent Director having DIN 11255979 and Retirement of an Independent Director having DIN 01478375 and other matters. (As Per BSE Announcement Dated on:29.08.2025) | ||
| Board Meeting | 14 Aug 2025 | 8 Aug 2025 |
| Integrated Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 inter alia to consider and approve Prior Intimation of Board Meeting and Trading Window Regulation 29 (1)(a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 Outcome of Board Meeting pursuant to Regulation 30, 32 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (SEBI LODR) (As Per BSE Announcement Dated on: 14.08.2025) | ||
| Board Meeting | 7 Aug 2025 | 31 Jul 2025 |
| Integrated Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2025 inter alia to consider and approve Intimation of Board Meeting under Regulation 29 of SEBI (LODR) Regulations 2015. Outcome of Board Meeting held today i.e., August 7, 2025 (As per BSE Announcement Dated on 07/08/2025) | ||
| Board Meeting | 1 Aug 2025 | 1 Aug 2025 |
| Outcome of Board Meeting held today i.e., August 1, 2025 | ||
| Board Meeting | 28 May 2025 | 23 May 2025 |
| Integrated Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2025 inter alia to consider and approve Audited Financial Result for the Quarter and Financial Year Ended on March 31 2025 along with the Auditors Report and Certificate for unmodified opinion Pursuant to Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015. Audited Financial Results For the Quarter and Financial year ended March 31, 2025 (As Per BSE Announcement Dated on :28.05.2025) | ||
| Board Meeting | 15 May 2025 | 15 May 2025 |
| Outcome of the meeting of the Board of Directors held on Thursday, May 15, 2025 | ||
| Board Meeting | 1 Apr 2025 | 1 Apr 2025 |
| Intimation of Appointment of Company Secretary and Compliance officer of the Company pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements )Regulations,2015 | ||
| Board Meeting | 5 Mar 2025 | 6 Mar 2025 |
| Announcement under Regulation 30 of SEBI (LODR)Regulations ,2015 for appointment of Internal Auditor Announcement under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements)Regulations ,2015 for appointment of Secretarial Auditor | ||
| Board Meeting | 25 Feb 2025 | 21 Feb 2025 |
| INTEGRATED PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/02/2025 inter alia to consider and approve 1) To consider and approve the Appointment of M/s B.B. Gusani and Associates Practicing Chartered Accountants (FRN : 140785W ) as Statutory Auditor of the Company to fill the casual vacancy arising from the resignation of previous Statutory Auditor i.e. DGMS and Co. subject to approval of the shareholders of the Company till the conclusion of the upcoming Annual General Meeting. 2) To appoint CS Ankita Tejas Shah Practising Company Secretary and Designated Partner of Vast & Co. Company Secretaries LLP as the Scrutinizer of the Company. 3) To approve and declare relevant date and to approve draft of Postal ballot notice. 1. Considered and approved the appointment of the M/s B.B. Gusani and Associates, Practicing Chartered Accountants (FRN:140785W ) as Statutory Auditor of the Company to fill the casual vacancy arising from the resignation of previous Statutory Auditor i.e. DGMS and Co. subject to the approval of the shareholders till the conclusion of the upcoming Annual General Meeting . The requisite details in compliance with Regulation 30 of the SEBI LODR Regulations, read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11th November 2024, are provided in Annexure-A. 2. Appointment of CS Ankita Tejas Shah, Practising Company Secretary and Designated Partner of Vast & Co. Company Secretaries LLP as the Scrutinizer of the General Meeting through Postal Ballot. 3. Approved the draft notice of the Postal Ballot. Announcement under Regulation 30-Appointment of Statutory Auditor to fill the casual Vacancy arising from the resignation of previous auditor (As per BSE Announcement Dated on 25/02/2025) | ||
| Board Meeting | 14 Feb 2025 | 11 Feb 2025 |
| INTEGRATED PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 inter alia to consider and approve the unaudited financial results for the quarter ended on December 2024 together with the Limited Review Report for the said period Pursuant to the provisions of Regulation 30 (read with Part A of Schedule III) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), and in continuation to our letter dated 11th February, 2025, we hereby report the outcome of the meeting of the Board of Directors held today, i.e. Friday, 14th February, 2025, inter-alia, to consider and approve the following: 1. Considered and approved the unaudited financial results for the quarter and nine months ended 31st December, 2024 together with the Limited Review Report by the Auditors. The Board meeting commenced at 2:30 PM and ended at 4:00 P.M. You are requested to take above on your records. (As Per BSE Announcement Dated on 14.02.2025) | ||
| Board Meeting | 4 Feb 2025 | 4 Feb 2025 |
| Outcome of Meeting of the board of the director of the company held on February 04, 2025 | ||
| Board Meeting | 3 Feb 2025 | 3 Feb 2025 |
| Outcome of Meeting of Board of Directors of the company held on February 03, 2025 | ||
| Board Meeting | 1 Feb 2025 | 1 Feb 2025 |
| Outcome of the Meeting of Board of Directors of the Company held today i.e. February 01, 2025 | ||
| Board Meeting | 28 Jan 2025 | 28 Jan 2025 |
| Allotment of 44,00,000 (Forty-Four Lakh) out of 2,00,00,000 (Two Crore) Convertible Equity Warrants on Preferential Basis to the allottees. | ||
| Board Meeting | 24 Jan 2025 | 24 Jan 2025 |
| Allotment of 20,00,000 (Twenty Lakh) out of 2,00,00,000 (Two Crore) Convertible Equity Warrants on Preferential Basis to the allottees. | ||
| Board Meeting | 10 Dec 2024 | 10 Dec 2024 |
| Outcome of Board Meeting held on Tuesday, 10th December, 2024 | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.